France, Italy and Spain among the 10 countries where Futura Medical has rolled out its Eroxon drug-free erectile dysfunction treatment in the opening six months of the year.

Consumer health manufacturer Uriach has agreed to acquire Germany's Pascoe Naturmedizin and through a separate transaction France's Laboratoires Ineldéa, following investment by private-equity firm ICG.

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

EFSA-commissioned report proposes changes to the way the authority conducts consultations on its scientific assessments which could give industry more opportunities for involvement.

A round-up of the latest health and wellness industry moves: Arkopharma appoints chief executive officer, PGEU names leadership team for 2025; PLT Health hires China BD director.

Germany's Stada has its eyes on expansion in the US dietary supplements market with the launch of histamine intolerance line Histasolv.